1. Institute of Human Genetics, Christian-Albrechts University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany;
2. Department of Pathology and Lymph Node Registry, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany;
3. MRC Toxicology Unit, University of Leicester, Leicester, United Kingdom;
4. Service d'Hematologie Biologique, Centre Hospitalier Lyon Sud, Lyon, France;
5. Department of Pathology, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC;
6. Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; and
7. Department of Internal Medicine III, University of Ulm, Ulm, Germany